CN102140415A - 一种养生酒 - Google Patents
一种养生酒 Download PDFInfo
- Publication number
- CN102140415A CN102140415A CN2011100271372A CN201110027137A CN102140415A CN 102140415 A CN102140415 A CN 102140415A CN 2011100271372 A CN2011100271372 A CN 2011100271372A CN 201110027137 A CN201110027137 A CN 201110027137A CN 102140415 A CN102140415 A CN 102140415A
- Authority
- CN
- China
- Prior art keywords
- wine
- health
- fruit
- red
- care wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 41
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 241000222336 Ganoderma Species 0.000 claims abstract description 11
- 235000005066 Rosa arkansana Nutrition 0.000 claims abstract description 10
- 241000109365 Rosa arkansana Species 0.000 claims abstract description 10
- 240000008042 Zea mays Species 0.000 claims abstract description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 3
- 235000005822 corn Nutrition 0.000 claims abstract description 3
- 230000036541 health Effects 0.000 claims description 21
- 241000804384 Cynomorium songaricum Species 0.000 claims description 9
- 235000014443 Pyrus communis Nutrition 0.000 claims description 9
- 240000007164 Salvia officinalis Species 0.000 claims description 9
- 235000005412 red sage Nutrition 0.000 claims description 9
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 claims description 2
- 235000019991 rice wine Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 239000003814 drug Substances 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 238000002791 soaking Methods 0.000 abstract 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000500125 Cynomorium coccineum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000004087 circulation Effects 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019990 fruit wine Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种养生酒。本发明所述养生酒包括灵芝、丹参、大枣、山里红、野玫瑰红、桑枝、锁阳、焦栀子、金樱子和玉须，本发明养生酒通过在酒中添加多种中药组分进行浸泡，浸泡后得到的养生酒含有丰富的营养成分和多种功效，具有滋阴补肾、补中益气、温经通脉、行气活血、养心安神的功效，适用于各种成年人群。
Description
技术领域
本发明属于养生酒领域，具体涉及一种以多种中药配制的养生酒。
背景技术
现有的中药养生酒种类繁多，对人体的保健作用也各有不同。但目前的养生酒中，绝大多数都是通过添加数十种中药组分制得的，由于不同中药之间存在着相辅相成或相互削减药效的微妙关系，并非添加的组分越多越好，而且添加太多的药物组分会导致药味过浓等问题。因此，如果可以找到一种添加中药组分少，减小中药之间的负面影响的养生酒配方，将具有巨大的市场前景。
发明内容
本发明的目的在于根据现有的养生酒中存在的组分复杂、药味过浓等问题，通过对祖传秘方的应用进行重新调整，再经过长时间的应用观察，提供一种添加中药组分少、成分相对简单、具有果酒的芬香的养生酒。
本发明上述养生酒包括酒、灵芝、丹参、大枣、山里红、野玫瑰红、桑枝、锁阳、焦栀子、金樱子和玉须。 本发明添加的上述中药组分中，灵芝性甘，平。归心、肺、肝、肾经。主治虚劳、咳嗽、气喘、失眠、消化不良，恶性肿瘤等。动物药理表明实验：灵芝对神经系统有抑制作用，循环系统有降压和加强心脏收缩力的作用，对呼吸系统有祛痰作用，此外，还有护肝、提高免疫功能，抗菌等作用。
丹参在心血管系统方面，具有：（1）加强心肌收缩力、改善心脏功能，不增加心肌耗氧量的作用；（2）扩张冠脉、增加心肌血流量、扩张外周血管、血流增加、脑血流量下降的作用；（3）提高纤溶酶活性、延长出、凝血时间；抑制血小板聚集（提高血小板内cAMP水平抑制TXA2合成）、改善血液流变学特性（血粘度降低、红细胞电泳时间缩短）的作用；（4）改善微循环；（5）坏死心肌清除、纤维母细胞分化、胶原纤维形成较明显、肉芽形成比较成熟、局部淤血减轻、血液循环改善、愈合时间缩短的作用；（6）对过度增生的纤维母细胞有抑制作用；（7）改善肝微循环的作用；（8）对体外的葡萄球菌、大肠杆菌和变形杆菌有抑制作用；（9）能使动脉粥样斑块形成面积显著减少，血清总胆固醇、甘油三酯具有一定程度的降低。
大枣具有免疫抑制作用、镇静催眠、降压、保肝，还可以治疗老年人气血津液不足，补脾和胃，胃虚食少，脾弱便溏等效果。
山里红具有治疗消化不良的功效，还能使不易消化的食品容易被人体消化吸收。同时还具有增强心肌、降低血脂、促进胆固醇转化等功能，对冠心病、高血压、动脉硬化具有一定疗效。
野玫瑰红味甘、酸，性温，归脾、肝，具有疏肝解郁、活血止痛等功效。
桑枝具有去风通络、尚达四肢、通利关节、痹症无论新旧、寒热均可应用、还可用于祛风止痒、皮疹瘙痒。
锁阳可以清除自由基、增强免疫力、耐缺氧、抗应激作用、通便、壮阳、抗炎、抗肿瘤等功效。
焦栀子味苦性寒，归心、肝、肺、胃、三焦经，用于血热吐衄，尿血崩漏，凉血解毒，泻火除烦。
金樱子具有抑制平滑肌作用、抗动脉粥样硬化作用和抗病原体作用。
玉须味甘、淡，性平。归肝、胆，具有利水消肿、利湿退黄的功效。
作为一种优选方案，所述酒为高粱酒、大米酒或玉米酒。
作为一种优选方案，本发明养生酒各组分的质量比为：酒50000:灵芝25~50:丹参20~30:大枣30~60:山里红20~30:野玫瑰红10~20:桑枝20~30:锁阳25~50:焦栀子15~30:金樱子15~30:玉须20~60。
作为一种更进一步的优选方案，本发明养生酒各组分的质量比为：酒50000:灵芝50:丹参30:大枣60:山里红30:野玫瑰红20:桑枝30:锁阳50:焦栀子30:金樱子30:玉须30。
与现有技术相比，本发明具有如下有益效果： （1）本发明选用多种成熟的中药，经过酒的浸泡后制得的养生酒含有丰富的营养成分：总皂甙、氨基酸、维生素A6、维生素E、镁、钾、钙、磷、铁、锰和锌等；
（2）本发明养生酒具有洋酒的色调、白酒的口感、果酒的芬香和药酒的功效，常饮能补气血、调阴阳、祛风寒、排湿毒、抗疲劳的功效。
具体实施方式
以下结合实施例来进一步解释本发明，但实施例并不对本发明做任何形式的限定。
实施例1 养生酒制备
酒100斤，灵芝50g，丹参30 g，大枣60 g，山里红30 g，野玫瑰红20 g，桑枝30 g，锁阳50 g，焦栀子30 g，金樱子30 g，玉须30 g。将各植物中药组分浸泡到酒里面，按照常规泡药酒工艺制备，得到本发明养生酒。
实施例2 养生酒制备
酒100斤，灵芝25g，丹参20 g，大枣30 g，山里红20 g，野玫瑰红10 g，桑枝20 g，锁阳25 g，焦栀子15 g，金樱子15 g，玉须50 g。将各植物中药组分浸泡到酒里面，按照常规泡药酒工艺制备，得到本发明养生酒。
Claims (4)
1.一种养生酒，其特征在于包括酒、灵芝、丹参、大枣、山里红、野玫瑰红、桑枝、锁阳、焦栀子、金樱子和玉须。
2.根据权利要求1所述的养生酒，其特征在于所述酒为高粱酒、大米酒或玉米酒。
3.根据权利要求1或2所述的养生酒，其特征在于各组分的质量比为：酒50000:灵芝25~50:丹参20~30:大枣30~60:山里红20~30:野玫瑰红10~20:桑枝20~30:锁阳25~50:焦栀子15~30:金樱子15~30:玉须20~60。
4.根据权利要求3所述的养生酒，其特征在于各组分的质量比为：酒50000:灵芝50:丹参30:大枣60:山里红30:野玫瑰红20:桑枝30:锁阳50:焦栀子30:金樱子30:玉须30。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110027137 CN102140415B (zh) | 2011-01-26 | 2011-01-26 | 一种养生酒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110027137 CN102140415B (zh) | 2011-01-26 | 2011-01-26 | 一种养生酒 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102140415A true CN102140415A (zh) | 2011-08-03 |
| CN102140415B CN102140415B (zh) | 2013-04-10 |
Family
ID=44408212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110027137 Active CN102140415B (zh) | 2011-01-26 | 2011-01-26 | 一种养生酒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102140415B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827747A (zh) * | 2012-09-05 | 2012-12-19 | 王应隆 | 一种养生露及其制备方法 |
| CN104232447A (zh) * | 2014-10-15 | 2014-12-24 | 王震 | 一种墨米金樱果酒的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1165855A (zh) * | 1997-05-09 | 1997-11-26 | 赵洪山 | 一种保健酒 |
| CN1381247A (zh) * | 2001-04-19 | 2002-11-27 | 金春煜 | 一种养生口服液 |
| CN1586544A (zh) * | 2004-07-14 | 2005-03-02 | 张国强 | 一种药酒及其制造方法 |
-
2011
- 2011-01-26 CN CN 201110027137 patent/CN102140415B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1165855A (zh) * | 1997-05-09 | 1997-11-26 | 赵洪山 | 一种保健酒 |
| CN1381247A (zh) * | 2001-04-19 | 2002-11-27 | 金春煜 | 一种养生口服液 |
| CN1586544A (zh) * | 2004-07-14 | 2005-03-02 | 张国强 | 一种药酒及其制造方法 |
Non-Patent Citations (1)
| Title |
|---|
| 李安陵: "关于保健酒的研发思考", 《酿酒》, vol. 36, no. 5, 30 September 2009 (2009-09-30), pages 87 - 90 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827747A (zh) * | 2012-09-05 | 2012-12-19 | 王应隆 | 一种养生露及其制备方法 |
| CN102827747B (zh) * | 2012-09-05 | 2013-11-20 | 王应隆 | 一种养生露及其制备方法 |
| CN104232447A (zh) * | 2014-10-15 | 2014-12-24 | 王震 | 一种墨米金樱果酒的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102140415B (zh) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103157005B (zh) | 一种补肾润发饮料产品及其制备方法 | |
| CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
| CN105455047A (zh) | 一种保健鲤鱼丸及其制备方法 | |
| CN103141839A (zh) | 一种玛卡沙棘片 | |
| CN103393100A (zh) | 一种膏产品 | |
| CN105331476A (zh) | 一种低醇葡萄酒及其制备方法 | |
| CN102140415B (zh) | 一种养生酒 | |
| CN103222621B (zh) | 补益机体抗氧化保健品 | |
| CN102078016A (zh) | 一种灵芝、山药饮品及其制备方法 | |
| CN108887683A (zh) | 一种药食养生的米饭添加剂及其制备工艺和药食养生米饭 | |
| CN107594252A (zh) | 一种葡萄汁保健饮品及其制备方法 | |
| CN104824195A (zh) | 养生功能保健食品 | |
| CN101455347A (zh) | 当归、黄芪、丹参营养泡腾饮片及其制造工艺 | |
| CN103893101A (zh) | 灵芝花粉防衰霜 | |
| CN107281084A (zh) | 一种美白中药面膜及其制备方法 | |
| CN101804125A (zh) | 龙眼保健酒 | |
| CN106954844A (zh) | 一种阿胶酵素保健品及其制备方法 | |
| CN102949683A (zh) | 温煦丹田浴足液 | |
| CN106900913A (zh) | 一种改善前列腺综合症状的花粉枸杞咖啡奶茶 | |
| CN108553598A (zh) | 天然保健益寿茶 | |
| CN101715957B (zh) | 一种具有提高耐缺氧功能的复方茶色素及其制备方法和应用 | |
| CN107811254A (zh) | 一种低脂醇香菌菇汤料 | |
| CN101971977A (zh) | 一种基于恶性肿瘤化疗患者的营养食品 | |
| CN106578254A (zh) | 一种美白养颜的奶茶 | |
| CN104474519A (zh) | 一种人参山药药酒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210721 Address after: 510075 No. 0164, 16 / F, Xingguang Yingjing, 119 Shuiyin Road, Yuexiu District, Guangzhou, Guangdong Patentee after: Guangdong Gangfu Wine AND Spirits Co.,Ltd. Address before: 510640 1104, No. 419, Dongguan Zhuang Road, Tianhe District, Guangzhou City, Guangdong Province Patentee before: Wang Ting |
|
| TR01 | Transfer of patent right |